Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials

BACKGROUND: Additional therapeutic strategies could benefit efforts to reverse the recent increase in malaria cases in sub-Saharan Africa, which mostly affects young children. A primary candidate is dihydroartemisinin + piperaquine (DHA + PPQ), which is effective for uncomplicated malaria treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wicht, Kathryn J, Small-Saunders, Jennifer L, Hagenah, Laura M, Mok, Sachel, Fidock, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704436/
https://www.ncbi.nlm.nih.gov/pubmed/36082431
http://dx.doi.org/10.1093/infdis/jiac365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704436/
https://www.ncbi.nlm.nih.gov/pubmed/36082431
http://dx.doi.org/10.1093/infdis/jiac365

Ejemplares similares